WHO vs FDA vs EU GMP: Documentation Requirements

📑 WHO vs US FDA vs EU GMP: Documentation Requirements

---

Purpose

Provide a comprehensive comparison of documentation requirements under WHO, US FDA, and EU GMP, highlighting audit focus areas and strategies for harmonized, inspection-ready systems.

Importance of Documentation

Documentation ensures:

• Traceability of processes, materials, and decisions
• Data integrity and accountability
• Compliance evidence during inspections
• Consistency and reproducibility of operations

“If it isn’t documented, it didn’t happen.”

WHO GMP Documentation

• Focus on essential SOPs, Master Formula, and Batch Records
• Simple structure suitable for global supply
• Limited electronic record emphasis
• Manual records acceptable if legible and controlled

US FDA GMP Documentation

• Highly detailed batch records for every step
• Mandatory deviation, investigation, CAPA documentation
• Strict data integrity and 21 CFR Part 11 enforcement
• Extensive audit trail review

EU GMP Documentation

• Risk-based, lifecycle documentation
• ALCOA+ compliance
• Annex 11, 15, 1 for computerized systems, validation, sterile operations
• Quality Risk Management applied to documentation

📊 Key Differences

Parameter	WHO	FDA	EU
Level of Detail	Moderate	Very High	High
Data Integrity	Basic	Strict	Very Strict
Audit Approach	Compliance	Enforcement	Risk-Based
Electronic Records	Limited	Extensive	Extensive

⚠️ Common Audit Observations & Tips

• Backdated or incomplete records
• Uncontrolled SOP versions
• Missing investigation documentation
• Poor CAPA implementation
• Weak data integrity controls
• Inadequate QA oversight

✅ Compliance Strategy

• Implement robust document control systems (manual or electronic)
• Ensure SOPs reflect actual practices
• Train staff on GDP & data integrity
• Strong QA review and approval mechanisms
• Periodic internal audits and checks
• Risk-based documentation aligned with EU GMP while maintaining FDA rigor

🎯 Conclusion

Harmonized documentation aligned with WHO, FDA, and EU GMP ensures compliance, traceability, data integrity, and patient safety. Audit-ready systems reduce risk and improve inspection outcomes.